Review Published on 01 Oct 2013 The Role of PARP Inhibitors in the Treatment of Gynecologic Malignancies in Cancer Molecular Targets and Therapeutics Raquel E. ReinboltJohn L. Hays Frontiers in Oncology doi 10.3389/fonc.2013.00237 19,828 views 54 citations